Synovial concentrations of the angiogenic peptides bFGF and VEGF do not discriminate rheumatoid arthritis from other forms of inflammatory arthritis

REFERENCES

• Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–7.
   PubMed Web of Science ®Google Scholar
• Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley PM, Israel NA, Liotta LA, editors. The molecular basis of cancer. Philadelphia: WB Saunders; 1995. p. 206–32
   Google Scholar
• Folkman J. Clinical applications of research on angiogenesis. N Engl J Med 1995; 333: 1757–63.
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1: 27–31.
   PubMed Web of Science ®Google Scholar
• Senger DR. Molecular framework for angiogen-esis. Am J Pathol 1996; 149: 1–7.
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biolo-gical functions of fibroblast growth factor. Endocr Rev 1987; 8: 95–114.
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029–39.
   PubMed Web of Science ®Google Scholar
• Qu Z, Huang XN, Ahmadi P, Andresevic J, Planck SR, Hart CE, Rosenbaum JT. Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995; 73: 339— 46.
   Google Scholar
• Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994; 180: 341–6.
   Google Scholar
• Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 4149–56.
   Google Scholar
• Nagashima M, Yoshino S, Asano G. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. J Rheumatol 1995; 22: 1624— 30.
   Google Scholar
• Moses MA, Sudhalter J, Lancer R. Isolation and characterization of an inhibitor of neovasculariza-tion from scapular chondrocytes. J Cell Biol 1992; 119: 475–82.
   Google Scholar
• Koch AE, Burrows JC, Polverini PJ, Cho M, Leibovich SJ. Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity. Agents Actions 1991; 34: 350–7.
   Google Scholar
• Billington DC. Angiogenesis and its inhibition: potential new therapies in oncology and non-neoplastic disorders. Drug Des Discov 1991; 8: 3–35.
   PubMedGoogle Scholar
• Peacock DJ, Banquerigo ML, Brahn E. Angiogen-esis inhibition suppresses collagen arthritis. J Exp Med 1992; 175: 1135–8.
   Google Scholar
• Oliver SJ, Chena TP, Banqueriao ML, Brahn E. Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combina-tion with cyclosporin: reduction of vascular endothelial growth factor (VEGF). Cell Immunol 1995; 166: 196–206.
   PubMed Web of Science ®Google Scholar
• Yamashita A, Yonemitsu Y, Okano S, Nakagawa K, Nakashima Y, Irisa T, Iwamoto Y, Nagai Y, Hasegawa M, Sueishi K. Fibroblast growth factor-2 determines severity of joint disease in adjuvant-induced arthritis in rats. J Immunol 2002; 168: 450 — 7.
   PubMed Web of Science ®Google Scholar
• Sone H, Sakauchi M, Takahashi A, Suzuki H, Inoue N, Iida K, Shimano H, Toyoshima H, Kawakami Y, Okuda Y, Matsuo K, Yamada N. Elevated levels of vascular endothelial growth factor in the sera of patients with rheumatoid arthritis correlation with disease activity. Life Sci 2001; 69: 1861–9.
   PubMed Web of Science ®Google Scholar
• Ballara S, Taylor PC, Reusch P, Marme D, Feldmann M, Maini RN, Paleolog EM. Raised serum vascular endothelial growth factor levels are associated with destructive change in inflamma-tory arthritis. Arthritis Rheum 2001; 44: 2055–64.
   Google Scholar
• Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 2001; 19: 321–4.
   PubMed Web of Science ®Google Scholar
• Brenchley PE. Antagonising angiogenesis in rheu-matoid arthritis. Ann Rheum Dis 2001; 60 Suppl 3: iii71 —4.
   Google Scholar
• de Bandt M, Grossin M, Weber AJ, Chopin M, Elbim C, Pla M, Gougerot-Pocidalo MA, Gaudry M. Suppression of arthritis and protection from bone destruction by treatment with TNP-470/ AGM-1470 in a transgenic mouse model of rheumatoid arthritis. Arthritis Rheum 2000; 43: 2056— 63.
   Google Scholar
• Miotla J, Maciewicz R, Kendrew J, Feldmann M, Paleolog E. Treatment with soluble VEGF recep-tor reduces disease severity in murine collagen-induced arthritis. Lab Invest 2000; 80: 1195–205.
   Google Scholar
• Sone H, Kawakami Y, Sakauchi M, Nakamura Y, Takahashi A, Shimano H, Okuda Y, Segawa T, Suzuki H, Yamada N. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 2001; 281: 562–8.
   PubMed Web of Science ®Google Scholar
• Storgard CM, Stupack DG, Jonczyk A, Goodman SL, Fox RI, Cheresh DA. Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist. J Clin Invest 1999; 103: 47–54.
   PubMed Web of Science ®Google Scholar
• Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RH. Quantitation and physiological characterization of angiogenic vessels in mice. Am J Pathol 1996; 149: 59–71.
   Google Scholar
• Barleon B, Hauser S, Schollmann C, Weindel K, Marme D, Yayon A, Weich HA. Differential expression of the two VEGF receptors fit and KDR in placenta and vascular endothelial cells. J Cell Biochem 1994; 54: 56–66.
   Google Scholar
• Marmé D. Tumor angiogenesis: pivotal role of vascular endothelial growth factor. World J Urol 1996; 14: 166–74.
   PubMed Web of Science ®Google Scholar
• Schreiber L. The endothelium in rheumatoid arthritis. In: Klippel JH, Dieppe PA, editors. Rheumatology. St. Louis: Mosby; 1994. p. 101–6
   Google Scholar
• Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T, Ariyoshi M, Saiki T, Sakamoto M, Nagata K, Sata M, Matsuo K, Tanikawa K. Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 1998; 27: 377–80.
   Google Scholar